News & Events

We are excited to announce a leadership change in ENOTTA Working Group 3, “Assay Standardisation and Structured Overview on Participating Hospitals/Research Centres.” We extend our heartfelt gratitude to Prof. Silje…

As part of our dissemination activities, the , held on 20-21 June 2024 in Montpellier, France. The workshop, titled “ENOTTA – European Network on Optimising Treatment with Therapeutic Antibodies in…

WG3 just opened a short survey focusing on External Quality A (EQA) schemes for therapeutic drug monitoring used to guide clinical decision making. If you would like to participate, the…

The Extended Core Group meeting of COST Action CA 21147 ENOTTA was held in the picturesque island of Lemnos, Greece, from May 29th to 31st, 2024! ENOTTA, the “European Network…

We’re thrilled to announce the publication of our first paper titled: “Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe” This…

We are excited to announce our upcoming webinar series  “Model-informed therapeutic drug monitoring of antibodies in chronic inflammatory diseases: Assembling a multidisciplinary puzzle“. The webinars will take place every second…

Based on results from the COST Action ENOTTA recent survey, ENOTTA members have penned an overview of laboratories active in the field of TDM of therapeutic antibodies and their approaches…

ENOTTA organized “The Health Economics and Outcomes Research Training School (HEOR)” from December 11 to 13, 2023, followed by the MC/WG meeting from December 13 to 15, 2023, in the…

We’re thrilled to announce that COST Action ENOTTA has caught the spotlight! The right drug at the right dose for the right patient Chronic inflammatory diseases affect 5% to 7%…